JOURNAL ARTICLE
Imaging of fibrolamellar hepatocellular carcinoma.
AJR. American Journal of Roentgenology 1988 August
The imaging studies of 12 patients with fibrolamellar hepatocellular carcinoma were reviewed in an attempt to characterize the appearance of the tumors and to stage them. The imaging studies showed that 10 (83%) of 12 tumors were solitary, one was multilobulated with several satellite nodules, and one was bilobed. Surface lobulations were present in nine (82%) of 11 tumors on CT, five of five on sonography, and seven (88%) of eight on angiography. A central scar was identified in five (45%) of 11 tumors on CT, three (60%) of five on sonography, and two (25%) of eight on angiography. Calcification was seen in six (55%) of 11 tumors on CT, four (80%) of five on sonography, and one (13%) of eight on plain films. The tumors were correctly staged as resectable or nonresectable by CT in eight (73%) of 11 patients, by sonography in four (80%) of five, and by angiography in five (63%) of eight. Understaging was responsible for all but one of the staging errors. Distinguishing fibrolamellar hepatocellular carcinoma from more common hepatocellular carcinoma can affect surgical planning and survival.
Full text links
Trending Papers
Role of Iron Deficiency in Heart Failure-Clinical and Treatment Approach: An Overview.Diagnostics 2023 January 14
Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment.Frontiers in Immunology 2022
Long COVID: major findings, mechanisms and recommendations.Nature Reviews. Microbiology 2023 January 14
2023 American Society of Anesthesiologists Practice Guidelines for Preoperative Fasting: Carbohydrate-containing Clear Liquids with or without Protein, Chewing Gum, and Pediatric Fasting Duration-A Modular Update of the 2017 American Society of Anesthesiologists Practice Guidelines for Preoperative Fasting.Anesthesiology 2023 Februrary 2
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app